SGMO Financial Statements

Balance sheet, income statement, cash flow, and dividends for Sangamo Therapeutics Inc (SGMO).


$212.82M Market Cap.

As of 03/17/2025 5:00 PM ET (MRY) • Disclaimer

SGMO Market Cap. (MRY)


SGMO Shares Outstanding (MRY)


SGMO Assets (MRY)


Total Assets

$101.64M

Total Liabilities

$78.86M

Total Investments

$0

SGMO Income (MRY)


Revenue

$57.80M

Net Income

-$97.94M

Operating Expense

$161.77M

SGMO Cash Flow (MRY)


CF Operations

-$67.14M

CF Investing

$37.52M

CF Financing

$28.38M

SGMO Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

SGMO Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$101,635,000 (-38.52%)

$165,320,000 (-70.61%)

$562,509,000 (-22.08%)

$721,923,000 (-23.08%)

Assets Current

$51,691,000 (-45.20%)

$94,328,000 (-68.59%)

$300,327,000 (-24.69%)

$398,769,000 (-39.55%)

Assets Non-Current

$49,944,000 (-29.65%)

$70,992,000 (-72.92%)

$262,182,000 (-18.87%)

$323,154,000 (15.87%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$88,281,000 (-5.54%)

$93,462,000 (-7.40%)

Shareholders Equity

$22,770,000 (-72.53%)

$82,887,000 (-71.90%)

$294,958,000 (-21.42%)

$375,343,000 (-24.67%)

Property Plant & Equipment Net

$34,756,000 (-34.26%)

$52,865,000 (-57.89%)

$125,533,000 (0.66%)

$124,704,000 (10.98%)

Cash & Equivalents

$43,418,000 (-7.04%)

$46,704,000 (-54.19%)

$101,944,000 (-43.48%)

$180,372,000 (35.79%)

Accumulated Other Comprehensive Income

-$7,530,000 (-63.87%)

-$4,595,000 (45.32%)

-$8,404,000 (-110.79%)

-$3,987,000 (-173.57%)

Deferred Revenue

$13,430,000 (0%)

$0 (0%)

$161,157,000 (-36.17%)

$252,487,000 (-25.01%)

Total Investments

$0 (0%)

$35,798,000 (-82.71%)

$207,033,000 (-27.57%)

$285,845,000 (-49.01%)

Investments Current

$0 (0%)

$35,798,000 (-79.80%)

$177,188,000 (-10.36%)

$197,676,000 (-61.25%)

Investments Non-Current

$0 (0%)

$0 (0%)

$29,845,000 (-66.15%)

$88,169,000 (74.49%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$526,000 (-43.01%)

$923,000 (-74.90%)

$3,678,000 (-38.83%)

$6,013,000 (15.10%)

Trade & Non-Trade Payables

$15,485,000 (1.48%)

$15,259,000 (-31.93%)

$22,418,000 (129.72%)

$9,759,000 (-22.26%)

Accumulated Retained Earnings (Deficit)

-$1,504,317,000 (-6.96%)

-$1,406,376,000 (-22.45%)

-$1,148,545,000 (-20.11%)

-$956,267,000 (-22.92%)

Tax Assets

$16,881,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$6,270,000 (-5.64%)

$6,645,000 (-7.52%)

Total Debt

$26,253,000 (-21.67%)

$33,515,000 (-14.03%)

$38,986,000 (-11.51%)

$44,055,000 (14.74%)

Debt Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Debt Non-Current

$26,253,000 (-21.67%)

$33,515,000 (-14.03%)

$38,986,000 (-11.51%)

$44,055,000 (14.74%)

Total Liabilities

$78,865,000 (-4.33%)

$82,433,000 (-69.19%)

$267,551,000 (-22.80%)

$346,580,000 (-21.44%)

Liabilities Current

$45,805,000 (-4.04%)

$47,731,000 (-57.27%)

$111,711,000 (-12.65%)

$127,887,000 (-10.91%)

Liabilities Non-Current

$33,060,000 (-4.73%)

$34,702,000 (-77.73%)

$155,840,000 (-28.74%)

$218,693,000 (-26.52%)

SGMO Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$57,800,000 (-67.20%)

$176,232,000 (58.34%)

$111,299,000 (0.54%)

$110,701,000 (-6.34%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$44,727,000 (-26.88%)

$61,167,000 (-2.42%)

$62,682,000 (-0.85%)

$63,219,000 (-5.78%)

Research & Development Expense

$111,521,000 (-52.35%)

$234,057,000 (-6.34%)

$249,898,000 (8.27%)

$230,819,000 (27.77%)

Operating Expenses

$161,769,000 (-64.07%)

$450,237,000 (44.04%)

$312,580,000 (6.31%)

$294,038,000 (18.69%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

-$167,000 (96.71%)

-$5,072,000 (-1282.28%)

$429,000 (40.20%)

$306,000 (-11.30%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$97,941,000 (62.01%)

-$257,831,000 (-34.09%)

-$192,278,000 (-7.84%)

-$178,297,000 (-47.20%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

-$11,000 (91.27%)

Net Income

-$97,941,000 (62.01%)

-$257,831,000 (-34.09%)

-$192,278,000 (-7.85%)

-$178,286,000 (-47.35%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$97,941,000 (62.01%)

-$257,831,000 (-34.09%)

-$192,278,000 (-7.85%)

-$178,286,000 (-47.35%)

Weighted Average Shares

$201,699,000 (15.62%)

$174,444,000 (13.02%)

$154,345,000 (6.76%)

$144,568,000 (7.53%)

Weighted Average Shares Diluted

$201,699,000 (15.62%)

$174,444,000 (13.02%)

$154,345,000 (6.76%)

$144,568,000 (7.53%)

Earning Before Interest & Taxes (EBIT)

-$98,108,000 (62.68%)

-$262,903,000 (-37.04%)

-$191,849,000 (-7.79%)

-$177,980,000 (-47.52%)

Gross Profit

$57,800,000 (-67.20%)

$176,232,000 (58.34%)

$111,299,000 (0.54%)

$110,701,000 (-6.34%)

Operating Income

-$103,969,000 (62.06%)

-$274,005,000 (-36.13%)

-$201,281,000 (-9.79%)

-$183,337,000 (-41.52%)

SGMO Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$37,524,000 (-75.56%)

$153,531,000 (158.97%)

$59,285,000 (-76.11%)

$248,199,000 (191.37%)

Net Cash Flow from Financing

$28,377,000 (94.52%)

$14,588,000 (-82.77%)

$84,660,000 (157.65%)

$32,858,000 (-78.54%)

Net Cash Flow from Operations

-$67,139,000 (70.14%)

-$224,842,000 (-0.54%)

-$223,627,000 (4.13%)

-$233,251,000 (-237.31%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$3,286,000 (94.05%)

-$55,240,000 (29.57%)

-$78,428,000 (-264.96%)

$47,543,000 (-6.60%)

Net Cash Flow - Business Acquisitions and Disposals

$1,951,000 (0%)

$0 (0%)

$0 (0%)

-$119,000 (83.10%)

Net Cash Flow - Investment Acquisitions and Disposals

$35,840,000 (-79.48%)

$174,686,000 (119.85%)

$79,456,000 (-70.74%)

$271,596,000 (206.01%)

Capital Expenditure

-$267,000 (98.74%)

-$21,155,000 (-4.88%)

-$20,171,000 (13.35%)

-$23,278,000 (-58.20%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$29,281,000 (82.54%)

$16,041,000 (-81.51%)

$86,764,000 (140.24%)

$36,116,000 (-76.53%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$2,048,000 (-238.10%)

$1,483,000 (18.26%)

$1,254,000 (576.81%)

-$263,000 (41.16%)

Share Based Compensation

$12,382,000 (-54.75%)

$27,363,000 (-13.55%)

$31,650,000 (-3.96%)

$32,956,000 (28.19%)

Depreciation Amortization & Accretion

$9,361,000 (-57.82%)

$22,192,000 (7.93%)

$20,562,000 (16.58%)

$17,638,000 (31.93%)

SGMO Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

Profit Margin

-169.40% (-15.79%)

-146.30% (15.34%)

-172.80% (-7.26%)

-161.10% (-57.32%)

EBITDA Margin

-153.50% (-12.37%)

-136.60% (11.24%)

-153.90% (-6.28%)

-144.80% (-59.47%)

Return on Average Equity (ROAE)

-275.30% (-110.15%)

-131.00% (-114.05%)

-61.20% (-45.71%)

-42.00% (-67.33%)

Return on Average Assets (ROAA)

-90.10% (-0.56%)

-89.60% (-182.65%)

-31.70% (-42.79%)

-22.20% (-55.24%)

Return on Sales (ROS)

-169.70% (-13.74%)

-149.20% (13.46%)

-172.40% (-7.21%)

-160.80% (-57.49%)

Return on Invested Capital (ROIC)

-184.00% (-36.70%)

-134.60% (-133.68%)

-57.60% (-45.09%)

-39.70% (-47.04%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-2.08 (-467.30%)

-0.37 (85.39%)

-2.51 (58.81%)

-6.1 (64.83%)

Price to Sales Ratio (P/S)

3.56 (561.52%)

0.54 (-87.64%)

4.35 (-55.54%)

9.79 (-44.83%)

Price to Book Ratio (P/B)

9.35 (704.39%)

1.16 (-33.41%)

1.75 (-40.05%)

2.91 (-34.29%)

Debt to Equity Ratio (D/E)

3.46 (248.14%)

0.99 (9.70%)

0.91 (-1.73%)

0.92 (4.29%)

Earnings Per Share (EPS)

-0.49 (66.89%)

-1.48 (-18.40%)

-1.25 (-1.63%)

-1.23 (-36.67%)

Sales Per Share (SPS)

0.29 (-71.58%)

1.01 (40.08%)

0.72 (-5.87%)

0.77 (-12.86%)

Free Cash Flow Per Share (FCFPS)

-0.33 (76.31%)

-1.41 (10.76%)

-1.58 (10.94%)

-1.77 (-253.73%)

Book Value Per Share (BVPS)

0.11 (-76.21%)

0.47 (-75.14%)

1.91 (-26.39%)

2.6 (-29.95%)

Tangible Assets Book Value Per Share (TABVPS)

0.5 (-46.84%)

0.95 (-69.15%)

3.07 (-29.31%)

4.35 (-30.22%)

Enterprise Value Over EBIT (EV/EBIT)

-2 (0%)

0 (0%)

-2 (60.00%)

-5 (68.75%)

Enterprise Value Over EBITDA (EV/EBITDA)

-2.25 (-638.36%)

-0.3 (88.60%)

-2.67 (54.86%)

-5.93 (67.97%)

Asset Turnover

0.53 (-13.21%)

0.61 (234.97%)

0.18 (32.61%)

0.14 (-1.43%)

Current Ratio

1.13 (-42.86%)

1.98 (-26.49%)

2.69 (-13.79%)

3.12 (-32.14%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$67,406,000 (72.60%)

-$245,997,000 (-0.90%)

-$243,798,000 (4.96%)

-$256,529,000 (-265.33%)

Enterprise Value (EV)

$199,845,807 (172.59%)

$73,313,614 (-84.00%)

$458,218,222 (-51.78%)

$950,226,432 (-52.12%)

Earnings Before Tax (EBT)

-$98,108,000 (62.68%)

-$262,903,000 (-37.04%)

-$191,849,000 (-7.79%)

-$177,980,000 (-47.52%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$88,747,000 (63.13%)

-$240,711,000 (-40.53%)

-$171,287,000 (-6.83%)

-$160,342,000 (-49.46%)

Invested Capital

$38,665,000 (-62.96%)

$104,400,000 (-65.15%)

$299,559,000 (-17.76%)

$364,257,000 (-39.25%)

Working Capital

$5,886,000 (-87.37%)

$46,597,000 (-75.30%)

$188,616,000 (-30.37%)

$270,882,000 (-47.52%)

Tangible Asset Value

$101,635,000 (-38.52%)

$165,320,000 (-65.14%)

$474,228,000 (-24.54%)

$628,461,000 (-24.97%)

Market Capitalization

$212,819,807 (120.88%)

$96,352,614 (-81.28%)

$514,583,222 (-52.90%)

$1,092,559,432 (-50.50%)

Average Equity

$35,572,750 (-81.92%)

$196,765,250 (-37.38%)

$314,228,750 (-25.94%)

$424,292,750 (-11.85%)

Average Assets

$108,718,250 (-62.21%)

$287,664,500 (-52.61%)

$606,964,500 (-24.29%)

$801,694,750 (-5.16%)

Invested Capital Average

$53,329,000 (-72.69%)

$195,258,500 (-41.38%)

$333,064,250 (-25.79%)

$448,801,000 (0.48%)

Shares

208,646,870 (17.65%)

177,346,980 (8.22%)

163,880,007 (12.50%)

145,674,591 (2.99%)